Systimmune
The Senior Scientist will work in the research and development division to establish and apply in vitro and in situ models for identifying and characterizing novel antibody therapeutics. The role involves evaluating immunological pathways, leading immuno‑oncology discovery/preclinical projects, and preparing reports and regulatory documents while collaborating with an interdisciplinary team.
Headquarters
Redmond, Washington, United States
Company Size
11-50 employees
Founded
2014
SystImmune is a Redmond, WA–based biopharmaceutical company developing bi‑specific and multi‑specific antibodies and antibody‑drug conjugates (ADCs) to treat cancer. Its mission is to create biologics that both directly attack tumors and activate the immune system to enhance anti‑tumor responses, using proprietary protein‑engineering and antibody‑discovery platforms. A multidisciplinary team across the U.S. and China focuses on rapid, cost‑efficient clinical development. SystImmune is a member of the Biokin Pharmaceutical group and partners with Bristol Myers Squibb and OrbiMed, and it is seeking additional collaborators to develop and commercialize its therapies worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Systimmune.
16% below the average for this role
Postdoctoral Research Fellow - Viral Immunology
The University of British Columbia
Associate Scientist, Therapeutic Antibodies
Regeneron Pharmaceuticals
Senior Scientist – Immunology
Trap
Research Associate
Medical College of Wisconsin
Scientist/Sr Scientist, Therapeutics
Earli, Inc.
Scientist, Discovery Oncology
MSD